Loading organizations...
Loading organizations...
Innovative drug R&D company developing immune cell therapy technologies.
China Immunotech has raised $31.0M across 1 funding round.
China Immunotech has raised $31.0M in total across 1 funding round.
China Immunotech has raised $31.0M in total across 1 funding round.
China Immunotech's investors include China Growth Capital, Beijing Changping Science Park Development, Fenghai Capital, Guangzhou Sanheyue, Sangel Capital, Start Point Advisors, Jianwei YUAN.
China Immunotech has raised $31.0M across 1 funding round. Most recently, it raised $31.0M Series B in October 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 11, 2021 | $31.0M Series B | China Growth Capital | Beijing Changping Science Park Development, Fenghai Capital, Guangzhou Sanheyue, Sangel Capital, Start Point Advisors, Jianwei YUAN |